Shi Qing Cheng
Director/Board Member at Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Profile
Shi Qing Cheng is currently the Vice Chairman at Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Prior to this, he graduated from Peking University with a graduate degree in 1999 and from Renmin University of China with an undergraduate degree in 1982.
Shi Qing Cheng active positions
| Companies | Position | Start |
|---|---|---|
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
 Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Director/Board Member | 17/11/2021 |
Training of Shi Qing Cheng
| Peking University | Graduate Degree |
| Renmin University of China | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
 | Health Technology |
- Stock Market
- Insiders
- Shi Qing Cheng
